The Effects of a Novel Nutritional Product on Nutrient Gaps and Gut Health in Active Adults

Inclusion Criteria:

• Provide voluntary signed and dated informed consent.

• Be in good health as determined by medical history and routine blood chemistries.

• > 1 year of resistance training experience (minimum of 2 days per week of resistancetraining session with free weights)

• Age between 18 and 40 yr (inclusive).

• Subject agrees to maintain existing dietary and physical activity patternsthroughout the study period.

• Subject is willing and able to comply with the study protocol.

Exclusion Criteria:

• History of unstable or new-onset cardiovascular/cardiorespiratory, liver, or renalconditions.

• History of diabetes or endocrine disorder.

• History of use of medications or dietary supplements known to confound the study orits endpoints.

• Alcohol consumption (more than 2 standard alcoholic drinks per day or more than 10drinks per week) or drug abuse or dependence within the past 6 months.

• Current smokers or smoking within the past month.

• History of hyperparathyroidism or an untreated thyroid condition.

• History of malignancy in the previous 5 years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin).

• Prior gastrointestinal bypass surgery (Lapband), etc.

• Other known gastrointestinal or metabolic conditions that might impact nutrientabsorption or metabolism, e.g., short bowel syndrome, Irritable bowel syndrome (IBS), diarrheal illnesses, history of colon resection, gastro paresis,Inborn-Errors-of-Metabolism (such as PKU).

• Chronic inflammatory condition (e.g., rheumatoid arthritis, Crohn's, ulcerativecolitis, Lupus, HIV/AIDS, etc.).

• Previous medical diagnosis of asthma, gout, or fibromyalgia.

• Pregnant women, women trying to become pregnant, women less than 120 days postpartumor nursing women.

• Known sensitivity to any ingredient in the test formulations as listed in theproduct label.

• Currently participating in another research study with an investigational product orhave been in another research study in the past 30 days.

• Any other conditions that, in the opinion of the medical staff, could confound theprimary endpoints or place the subject at increased risk of harm if they were toparticipate.